"At The MHP Radiation Oncology Institute - part of Genesiscare network, we offer multidisciplinary personalized cancer treatments based on individual patient needs. From the latest techniques and cutting-edge technologies to our highly skilled team of physicians, we provide world-class cancer care close to home."

During the past decade, GenesisCare USA - Troy conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 6 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 5 clinical trials were completed. i.e. 29.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GenesisCare USA - Troy" #1 sponsor was "NRG Oncology" with 14 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GenesisCare USA - Troy" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "GenesisCare USA - Troy" are "Prostate Adenocarcinoma" (5 trials), "Prostate Cancer" (4 trials), "Stage II Lung Cancer AJCC v8" (3 trials), "Stage II Prostate Adenocarcinoma" (3 trials) and "Stage III Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "GenesisCare USA - Troy" in a lesser frequency.

Most popular intervention types in "GenesisCare USA - Troy" are "Radiation" (24 trials), "Drug" (22 trials), "Other" (12 trials), "Procedure" (7 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Radiation Therapy" (7 trials), "Bicalutamide" (5 trials), "Cisplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare USA - Troy" are 15 trials for "All" genders, 14 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "GenesisCare USA - Troy". undefined are not yet recruiting, 14 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GenesisCare USA - Troy, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare USA - Troy, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".